Welcome to LookChem.com Sign In|Join Free
  • or
Methyl 5-(broMoMethyl)-6-Methoxynicotinate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

234098-50-1

Post Buying Request

234098-50-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

234098-50-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 234098-50-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,3,4,0,9 and 8 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 234098-50:
(8*2)+(7*3)+(6*4)+(5*0)+(4*9)+(3*8)+(2*5)+(1*0)=131
131 % 10 = 1
So 234098-50-1 is a valid CAS Registry Number.

234098-50-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-Bromomethyl-6-methoxy-nicotinic acid methyl ester

1.2 Other means of identification

Product number -
Other names Methyl 5-(bromomethyl)-6-methoxynicotinate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:234098-50-1 SDS

234098-50-1Downstream Products

234098-50-1Relevant academic research and scientific papers

1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS

-

Paragraph 00173, (2021/08/06)

Compounds according to formula I are useful as agonists of Toll-like receptor 7 (TLR7). Such compounds can be used in cancer treatment, especially in combination with an anti-cancer immunotherapy agent, or as a vaccine adjuvant.

Substituted oxoazaheterocyclyl compounds

-

Page/Page column 75, (2008/06/13)

This invention is directed to oxoazaheterocycyl compounds which inhibit Factor Xa, to oxoazaheterocycyl compounds which inhibit both Factor Xa and Factor IIa, to pharmaceutical compositions comprising these compounds, to intermediates useful for preparing these compounds, to a method of directly inhibiting Factor Xa and to a method of simultaneously directly inhibiting Factor Xa and Factor IIa..

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 234098-50-1